SCHEDULE 13G/A: Investment Funds Disclose 4.9% Stake in Autonomix Medical

CVI Investments, Inc. and Heights Capital Management, Inc. have jointly disclosed a beneficial ownership of 4.9% in Autonomix Medical, Inc., totaling 116,087 shares.

Summary

• CVI Investments, Inc. and Heights Capital Management, Inc. (Reporting Persons) have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Autonomix Medical, Inc.
• As of December 31, 2024, the Reporting Persons collectively beneficially own 116,087 shares of Autonomix Medical, Inc. common stock.
• This ownership represents 4.9% of the company's outstanding common stock.
• Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and exercises shared voting and dispositive power over these shares.
• The shares reported as beneficially owned consist of shares issuable upon the exercise of warrants to purchase shares.
• The warrants are not exercisable to the extent that beneficial ownership would exceed 4.99%.
• The calculation of beneficial ownership is based on 2,039,495 shares outstanding, adjusted for shares issued upon exercise of pre-funded warrants.

Sentiment

Score: 6

Explanation: The filing is neutral in tone, as expected for a beneficial ownership report. The presence of institutional investors holding a significant stake (just under 5%) can be seen as a positive signal of confidence in the company, hence a slightly positive score.

Positives

• Significant investment by institutional funds (CVI Investments, Inc. and Heights Capital Management, Inc.) indicates confidence in Autonomix Medical, Inc.
• The investment is structured with warrants, potentially providing future capital to the company upon exercise.

Negatives

• The stake is just below the 5% threshold, which might limit the influence the investors can exert without triggering more extensive reporting requirements (Schedule 13D).

Risks

• The beneficial ownership is primarily through warrants, meaning the actual shares are not yet fully held, and their exercise is subject to a 4.99% beneficial ownership cap.

Future Outlook

The document is a beneficial ownership report and does not contain forward-looking statements or guidance from the company or the reporting persons regarding future operations or financial performance, beyond the nature of their current investment.

Management Comments

• "Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein."
• "Each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing indicates a significant institutional investment in Autonomix Medical, Inc., a company likely in the medical device or biotechnology sector given its name. Such investments are common for growth-oriented companies, providing capital and signaling investor confidence, particularly after a recent offering.

Comparison to Industry Standards

• This is a standard Schedule 13G filing reporting beneficial ownership below the 5% threshold, which is typical for passive investors.
• There are no specific comparable companies or projects mentioned in the document to allow for a detailed comparison of results.
• The 4.9% stake is a common level for institutional investors who wish to avoid the more stringent reporting requirements of a Schedule 13D, which applies to stakes of 5% or more acquired with the intent to influence control.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may provide a degree of confidence or validation for existing and potential shareholders.
• Company Management: Awareness of a large institutional holder may influence strategic decisions, though the filing states the shares are not held for the purpose of changing or influencing control.

Next Steps

• The document does not specify any future actions or milestones for Autonomix Medical, Inc. or the Reporting Persons beyond the ongoing passive investment.

Key Dates

Keywords

Autonomix Medical, CVI Investments, Heights Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Investment Management, SEC Filing